Anirban Sengupta

About

Biomedical immunologist investigating host immune response against pathogens for discovering mechanistic pathways, disease signatures, biomarkers leading to patient stratification & precision medicine

Employment

• Karolinska Institutet Postdoctoral Researcher
  2023 - Present
• Linköping University Postdoctoral Fellow
  2021 - 2023
• Ramakrishna Mission Vidyamandira Guest Lecturer of Zoology
  2020 - 2022
• Jadavpur University Guest Faculty, Paper Setter and Examiner
  2016 - 2020
• University of Calcutta PhD Research Fellow
  2014 - 2020
• National Institute of Biomedical Genomics Junior Research Fellow
  2011 - 2013

Education

• Bharathiar University Master of Science in Applied Psychology
• Maulana Azad College Master of Science in Zoology

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Sex-Specific Immune Responses to Seasonal Influenza Vaccination in Diabetic Individuals: Implications for Vaccine Efficacy
  Journal of Immunology Research 2023 DOI: 10.1155/2023/3111351
  +Save
• Administration of soluble gp130Fc disrupts M-1 macrophage polarization, dendritic cell activation, MDSC expansion and Th-17 induction during experimental cerebral malaria
  International Immunopharmacology 2023 DOI: 10.1016/j.intimp.2023.110671
  +Save
• A Time Travel with Anti-Malarial Drugs: Then, Now and Beyond
  Recent Trends and The Future of Antimicrobial Agents - Part I 2023 DOI: 10.2174/9789815079609123010010
  +Save
• Estimating nitric oxide (NO) from MDSCs by Griess method
  Methods in Cell Biology 2023 DOI: 10.1016/bs.mcb.2023.07.004
  +Save
• CD4+IL9+ (Th9) cells as the major source of IL-9, potentially modulate Th17/Treg mediated host immune response during experimental cerebral malaria.
  Molecular immunology 2022 DOI: 10.1016/j.molimm.2022.11.005
  +Save
• IL-6 dependent expansion of inflammatory MDSCs (CD11b+ Gr-1+) promote Th-17 mediated immune response during experimental cerebral malaria.
  Cytokine 2022 DOI: 10.1016/j.cyto.2022.155910
  +Save
• Efficacy and Immune Response Elicited by Gold Nanoparticle-Based Nanovaccines against Infectious Diseases
  Vaccines 2022 DOI: 10.3390/vaccines10040505
  +Save
• Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein
  Vaccines 2022 DOI: 10.3390/vaccines10040504
  +Save
• Nano toolbox in immune modulation and nanovaccines
  Trends in Biotechnology 2022 DOI: 10.1016/j.tibtech.2022.03.011
  +Save
• Partial impairment of late-stage autophagic flux in murine splenocytes leads to sqstm1/p62 mediated nrf2-keap1 antioxidant pathway activation and induced proteasome-mediated degradation in malaria
  Microbial Pathogenesis 2020 DOI: 10.1016/j.micpath.2020.104289
  +Save